# To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet

> **NCT06376838** · NA · COMPLETED · sponsor: **DEXLEVO** · enrollment: 218 (actual)

## Conditions studied

- Crow's Feet Lines

## Interventions

- **DEVICE:** DLMR01
- **DEVICE:** Rejuran

## Key facts

- **NCT ID:** NCT06376838
- **Lead sponsor:** DEXLEVO
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-07
- **Primary completion:** 2021-10-15
- **Final completion:** 2023-05-04
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06376838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06376838, "To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06376838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*